Central Nervous System Diseases
Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
Subtype terms (8)
More specific conditions that are subtypes of Central Nervous System Diseases in the MeSH hierarchy.
- Brain Diseases
145 drugs (88 approved, 57 experimental)
- Central Nervous System Infections
8 drugs (7 approved, 1 experimental)
- High Pressure Neurological Syndrome
- Hyperekplexia
- Movement Disorders
32 drugs (16 approved, 16 experimental)
- Ocular Motility Disorders
3 drugs approved
- Pneumocephalus
1 drug approved
- Spinal Cord Diseases
26 drugs (19 approved, 7 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (16)
Phase 3 trials (12)
Phase 2 trials (30)
- abemaciclib
- ketamine
- encenicline
- levodopa
- pembrolizumab
- fluoxetine
- p03277
- perifosine
- sodium phenylbutyrate
- trastuzumab
- preladenant
- propranolol
- elacestrant
- sagopilone
- ceftriaxone
- rotigotine
- temozolomide
- Ursodoxicoltaurine
- finasteride
- testosterone
- tucatinib
- umbilical cord mesenchymal stem cells
- midazolam
- thiotepa
- omega-3 fatty acids
- olive
- xpro1595
- jaci-35.054
- aci-35.030
- rvp-001
Phase 1 trials (21)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (34)
- AC Immune SA
- Seattle Genetics
- Merck
- Eli Lilly
- Amylyx Pharmaceuticals Inc.
- FORUM Pharmaceuticals Inc
- INC Research
- North Florida Foundation for Research and Education
- National Center for Research Resources (NCRR)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Cedars-Sinai Medical Center
- Harvard University
- Memorial University of Newfoundland
- University of Florida
- University of Toronto
- University of Waterloo
- Dalhousie University
- University of British Columbia
- University of Calgary
- University of Amsterdam
- BASF
- Janssen Pharmaceutica NV
- University of Alabama, Birmingham
- Department of Veteran Affairs
- ALS Association
- Brain Canada
- Breast Cancer Research Foundation
- Applied Health Research Centre
- ALS Finding a Cure Foundation
- Northeast ALS Consortium
- +4 more
Organization Involved with Phase 1 Indications (15)
Organization Involved with Other Experimental Indications (4)